267 Pseudoprogression patterns: Analysis from 2 independent phase-2 studies with immunotherapy for recurrent cervical cancer

Ähnliche Einträge

• 479 AGEN1181, an Fc-enhanced anti-CTLA-4 antibody, alone and in combination with balstilimab (anti-PD-1) in patients with advanced solid tumors: Initial phase I results
  von: Andrea Bullock, et al.
  Veröffentlicht: (2021-11-01)
• On NCT- Set Theory
  von: Dheargham Ali Abdulsada, et al.
  Veröffentlicht: (2024-06-01)
• Evaluation of sodium borocaptate (BSH) and boronophenylalanine (BPA) as boron delivery agents for neutron capture therapy (NCT) of cancer: an update and a guide for the future clinical evaluation of new boron delivery agents for NCT
  von: Rolf F. Barth, et al.
  Veröffentlicht: (2024-08-01)
• A nonrandom association of sarcoidosis in patients with gastrointestinal stromal tumor and other sarcomas
  von: Andrea P Espejo, et al.
  Veröffentlicht: (2018-07-01)
• 267 Pseudoprogression patterns: Analysis from 2 independent phase-2 studies with immunotherapy for recurrent cervical cancer
  von: Isabelle Ray-Coquard, et al.
  Veröffentlicht: (2020-11-01)